Kapstone Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$232K Hold
252
0.11% 124
2025
Q4
$271K Buy
+252
New +$241K 0.13% 96
2025
Q2
Sell
-252
Closed -$208K 124
2025
Q1
$208K Hold
252
0.12% 99
2024
Q4
$203K Sell
252
-514
-67% -$426K 0.11% 102
2024
Q3
$672K Buy
766
+256
+50% +$230K 0.41% 47
2024
Q2
$462K Buy
510
+45
+10% +$36K 0.3% 58
2024
Q1
$362K Hold
465
0.25% 69
2023
Q4
$292K Buy
+465
New +$271K 0.23% 78

Other funds holding LLY

Kapstone Financial Advisors's LLY Position: Q1 2026 in Review

Kapstone Financial Advisors held its Eli Lilly (LLY) position steady in Q1 2026 at 252 shares worth $232K. The position accounts for 0.11% of the portfolio, ranked #124.

Kapstone Financial Advisors first reported a position in LLY in Q4 2023 and has held it in 8 quarters since. The position peaked at $672K in Q3 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Kapstone Financial Advisors held 252 shares of Eli Lilly worth $232K as of Q1 2026.
  • Kapstone Financial Advisors left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.11% of Kapstone Financial Advisors's portfolio in Q1 2026, its #124 holding.
  • Kapstone Financial Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 8 quarters since.
  • Kapstone Financial Advisors's Eli Lilly position peaked at $672K in Q3 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Kapstone Financial Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.